Real-time enrollment status for this alcoholic liver disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06613698 |
| Recruiting Status | Recruiting |
| Condition | Alcoholic Liver Disease |
| Phase | Clinical Trial |
| Target Enrollment | 393 participants |
| Active Locations | 11 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | February 12, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT06613698 is currently recruiting participants. This clinical trial study for alcoholic liver disease is actively seeking new participants at 11 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06613698 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06613698 was last updated 2 weeks ago (February 12, 2026). HelloStudys verifies this status automatically.